$0.88-0.2%Nov 13 close
The latest quarter (ended September 30, 2026) is from Senestech’s earnings press release of November 10, 2026. It will be replaced by the official quarterly report (10-Q) once Senestech files it.
Just reported
From Senestech, Inc.'s results release of November 10, 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
$1.1M
+59% y/y
+42% q/q
Guided
—
No guide given
Actual
-$2M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $1.1M | $690K | +58.99% |
| Profit | -$2M | -$1.3M | -50.69% |
| Free Cash Flow | -$1.3M | -$1.4M | +5.70% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Senestech, Inc. reported on November 10, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“SenesTech delivered a milestone third quarter, exceeding $1 million in quarterly revenue for the first time and setting new records for revenue, gross profit and subscription customers,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
SenesTech is the leader in rodent birth control and sustainable rodent population management, with a mission to support a healthier environment through the responsible management of animal pest populations. The Company’s Evolve® and ContraPest® fertility control solutions, along with its assessment and monitoring services, target reproduction to help reduce rodent populations. SenesTech serves consumer and professional markets with proven approaches that can be used independently or as part of an integrated pest management (IPM) program.
The company’s own description, as it appears at the foot of the release.
The quote, the company description and the latest quarter come from Senestech’s earnings press release (an Item 2.02 8-K) filed November 10, 2026. Earlier quarters come from its quarterly and annual reports, and the latest will be replaced once the official report is filed. Read the release on EDGAR Share prices are split- and dividend-adjusted.